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1810-41 Remodeling of the Vascular Endothelium Following
PTCA In Rabbit iliac Arteries with Fibrin
Adhesive/Endothelial Cell Matrix
John E. Baker. Victor Nikolaychik. Harry Sahota, Richard Komarowski, Sean
D. Keane, Michael H. Keelan. Nicholas Kipshidze Medical College of Wisconsin,
Milwaukee, WI
We proposed that a possible cause of acute and chronic complications of
Percutaneous Transluminal Coronary Angioplasty (PTCAI is the loss of the
endothelial cell lining of the arterial wall. The objective of this study was to
reattach endothelial cells to the arterial wall at the time of PTCA. We devised
a unique process utilizing a delivery device whereby a fibrin adhesive reat-
taches endothelial cells to denuded vessel walls at the time of PTCA. Follow-
ing in vitro definition of optimal conditions required forthe adhesive matrix to
successfully reattach endothelial cells to an inert plastic surface and subse-
quent demonstration of viability of these cells after delivery through the infu-
sion catheter system, studies were carried out on iliac arteries (n = 6/group)
of New Zealand White rabbits subjected to balloon angioplasty-induced en-
dothelial cell denudation. The Wolinsky infusion balloon (USCI. C.R. Bard)
and double balloon was used to deliver the fibrin adhesive/endothelial cell
matrix labelled with red fluorescent dye to denuded areas over a 3-5 min
period. Immediately following treatment blood was allowed to perfuse the
seeded artery for four hours to expose the iliac segments with newly at-
tached endothelial cells to physiologic shear forces. Histological examination
demonstrated the ability of this novel method to circumferentially reattach
the adhesive/endothelial cell matrix to 70-90% of the denuded arterial wall
segments in comparison with 5-8% reattachment following seeding with en-
dothelial cells alone. We conclude that endothelial cells can be successfully
reattached to denuded vessel walls with a fibrin adhesive matrix following
PTCA.
Perfusion and Ventricular Function
- Myocardial Infarction/Unstable Angina
Wednesday, March 22, 1995,4:00 p.m.-5:00 p.m.
Ernest N. Morial Convention Center, Room 24
4:00
~ Evolution of Left Ventricular Function, Myocardial
Perfusion and Metabolism in Infarct Patients After
Coronary Thrombolysis
Alex F. Maes, Johan L. Nuyts, Luc A. Mortelmans, Guy M. Bormans, Alfons
M. Verbruggen, Frans Van de Werf University Hospital Gasthuisberg, Belgium
Follow-up of regional myocardial blood flow, metabolism and function was
studied in a population of thrombolysed patients. Fifty one patients with
an acute myocardial infarction were prospectively enrolled. All patients re-
ceived thrombolytic therapy within 6 hours after the onset of symptoms.
Coronary angiography, 2D-echocardiography and 13NH3/18FDG PET were
performed 5 days after the acute event. Three months after the infarction,
2D-echocardiography and 13NH3/18FDG PET studies were repeated.
Thirty six patients 162% with TIMIIII, 7% with TIMIII) revealed a concordant
decrease of flow and metabolism in the infarct area (PET match). Fifteen
patients (33% with TIMI III, 13% with TIMI II) revealed a decrease of flow
with preservation of metabolism (PET mismatch). Twelve patients received
further treatment (PTCA or CAGB) after the first PET scan. Myocardial blood
flow improved significantly in both match (71 ± 17 ml!min/l 00 gat 3 months
versus 60 ± 17 ml/min/100 g at 5 days, p < 0.01) and mismatch groups (71
± 26 ml/min/l00 g at 3 months versus 63 ± 18 ml/min/100 g at 5 days, p
< 0.05). Blood flow in remote areas did not change significantly (84 ± 18
mllmin/l 00 g at 3 months versus 82 ± 19 ml!min/l 00 gat 5 days, p = NS). In
4 patients with a match pattern at 5 days, a mismatch pattern had developed
3 months after the acute event.
Functional follow-up was performed in 30 patients, 23 with a match pattern
and 7 with a mismatch pattern. A variable outcome was observed: In 3 out
of 7 mismatch areas contractility did not improve. On the contrary, 9 out of
23 match areas revealed functional improvement.
It can be concluded that in this population of early thrombolysed patients,
few mismatches were observed (29%). Flow values improved significantly in
both match and mismatch groups 3 months after the acute event. In some
patients, a mismatch pattern was found after 3 months, suggesting the need
for further treatment. Functional outcome was variable, probably due to a va-
riety of pathophysiologic processes such as stunning shortly after reperfu-
sion with functional improvement after 3 months, reocclusion or progression
of coronary artery disease resulting in reinfarction or hibernation.
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1811-21 Evidence that Myocardial Stunning Occurs in
Humans Following Unstable Angina
William Wijns, Jean L. Vanoverschelde, Bernhard Gerber, Joszef Bartunek,
Bernard De Bruyne, Guy R. Heyndrickx, Jacques A. Melin. University of Louvain,
Brussels, Belgium; Cardiovascular Center, Aalst, Belgium
Reversible postischemic dysfunction, or myocardial stunning, is a well
defined experimental entity which is characterized by the presence of a
perfusion-contraction mismatch, i.e. the persistence of segmental dysfunc-
tion despite complete restoration of nutritive perfusion. Reversible dysfunc-
tion occurs following ischemic syndromes such as non-O wave infarction,
unstable angina, cardio-pulmonary bypass. Definite demonstration that re-
versible dysfunction indeed represents myocardial stunning is lacking, ow-
ing to the difficulty of measuring myocardial blood flow (MBF) in absolute
terms. Therefore, we measured regional wall motion (by 2D echo) and abso-
lute MBF with 13N-ammonia and positron emission tomography (PET) in 11
patients with unstable angina, Despite successful PTCA of the culprit lesion
on the left anterior descending coronary artery, all patients showed persis-
tent anterior. wall dysfunction at the time of the PET study (within 48 hours
after PTCA). As judged from the changes in segmental wall motion (in 6 ± 2
abnormal segments, mean ± sd, out of 16 in each patient) from the time of
PET study to 4-8 weeks later, regional dysfunction was entirely reversible in
9/11 patients. In these 9 patients, the segmental wall motion score improved
from 2.4 ± 0.3 to 1.2 ± 0.1 at late follow-up. With PET, 13N-ammonia MBF
was within the normal range in 8/9 patients (95 ± 21 mllmin/l 00 g, range 60-
124 ml/min/l 00 g), while it was decreased (33 ml/min/l00 g) in the remain-
ing patient. On average, in the 9 patients, absolute MBF was similar among
stunned and remote normally contracting myocardial segments (88 ± 28 vs
85 ± 25 ml!min/100 g, p = ns). Our data thus show perfusion-contraction
mismatch, confirming that myocardial stunning can occur in humans follow-
ing attacks of unstable angina.
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1811-31 Beneficial Effect of P-Blockade on Myocardial Blood
Flow and Vasodilator Capacity in Humans
Morten Bottcher, Johannes Czemin, Michael Phelps, Heinrich Schelbert. UCLA
School of Medicine, Los Angeles, CA
fit-receptor blockade reduces cardiac work and might thereby lower myocar-
dial blood flow (MBF) at rest. However, the effect of fil-blockade on hyper-
emic MBF is unknown. To evaluate the net effect of fil-receptor blockade
(Metoprolol, 50 mg p.o. 12 hours and 1 hour prior to the study) on MBF at
rest and during dipyridamole (DIP) induced hyperemia 10 healthy volunteers
(mean age: 24 ± 5 years; 8 males, 2 females) were studied with serial N-13
ammonia PET (2 compartment model) at control and again after fit-receptor
blockade. The resting rate pressure product (RPP) declined from 6621 ± 555
at control to 5168 ± 975 (p < 0.05) during Metoprolo!. Resting heart rate
(HR) decreased from 63 ± 6 to 54 ± 5 beats/min (p < 0.05). Similarly, the
RPP declined from 10193 ± 1330 during baseline DIP to 8575 ± 1770 (p <
0.05) during DIP + Metoprolol. Resting MBF declined in proportion to cardiac
work by 20% from 0.61 ± 0.10 to 0.51 ± 0.11 ml!g/min (p < 0.05). Overall,
resting MBF was linearly related to the RPP (y = 0.00003x + 0.134; r = 0.67;
P < 0.005). Thus, resting MBF normalized to the RPP *(105) did not change
from baseline to fi,-blockade (0.91 ± 0.1 vs 0.99 ± 0.19; p = NS). Hyperemic
MBF increased from 1.86 ± 0.28 to 2.40 ± 0.70 ml!g/min during (p < 0.05).
The decrease in resting MBF together with the increase in hyperemic MBF
during fi-blockade resulted in a significant increase in the myocardial flow
reserve (MFR) from 3.16 ± 0.80 to 4.74 ± 0.73; p < 0.01) Coronary vascular
resistance (mean arterial blood pressure/MBF) did not differ at rest (140 ±
27 vs 127 ± 22 mmHg/ml!g/min) but declined during DIP from 42 ± 7 to 32
± 7 mmHg/ml/g/min during DIP + Metoprolol (p < 0.05). Thus, resting MBF
decreases with fil-blockade in proportion to the decrease in cardiac work
which contributes to the improvement in flow reserve. At the same time, fi,-
blockade modulates hyperemic MBF most likely because of a) fil-blocker
induced negative inotropy which reduces extravascular compressive forces,
and/or b) decreases in heart rate which increases the duration of the diastolic
flow phase.
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Coronary Doppler Flow Velocity and PET Myocardial
Blood Flow are Highly Correlated and Predict
Post·lnfarction Perfusion In Patients with TIMI 3 Flow
Richard E. Stewart, Terry R. Bowers, Richard Ponto, D. Douglas Miller, William
W. O'Neill, Cindy L. Grines, Robert D. Salian, Jack E. Juni William Beaumont
Hospital, Royal Oak, Michigan
TIMI flow grades are used to assess the degree of coronary flow during acute
